CAS: 2126-78-5; Lysergic Acid Diethylamide
该化合物是Serotonin和多巴胺受体,这可能会对情绪,感觉和认知产生影响.该化合物的溶性,稳定性和再活性可因环境条件和其他物质的存在而变化.与该类别中的许多化合物一样,安全和毒性剖面对于了解其潜在的治疗用途和风险至关重要.
- 英文名称Lysergic Acid Diethylamide
- 中文名称(8α)-9,10-二去氢-N,N-二乙基-6-甲基麦角灵-8-甲酰胺
- IUPAC名称(6aR,9S)-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
- 其它别名Isolysergamide,N,N-diethyl- (6CI,7CI); Indolo[4,3-fg]quinoline, ergoline-8-carboxamide deriv.; (+)-Isolysergic acid diethylamide; D-Iso-LSD; D-Isolysergic acid diethylamide; D-iso-Lysergic acid N,N-diethylamide; Iso-LSD; Iso-lysergide; Isolysergic aciddiethylamide; N,N-Diethylisolysergamide; iso-LSD
- CAS编号2126-78-5
- MFCD编号:MFCD01076514
- EINECS号:899-459-5
- FDA UNII编号:R1XBQ6NTFR
- 分子式:C20H25N3O分子量:323.44
- 产品CID: 1098878
- 产品分类有机原料 → 生物碱及其衍生物 → 麦角林及其衍生物
物理性质
MSDS等安全信息
- GHS象形图
- GHS符号GHS08 & GHS06;
注释: Health hazard & Skull and crossbones - 危险类别致癌性 类别2
急性毒性 类别2(吸入)
急性毒性 类别2(经皮)
急性毒性 类别2(经口) - 警示词Danger(危险)
- 危险描述H351 |怀疑致癌.
H330 |吸入致命.
H310 |皮肤接触致命.
H300 |吞咽致命. - 防范说明P210-P233-P240-P241-P242-P243-P261-P264-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P312-P321-P362+P364-P337+P313-P370+P378-P403+P235-P501
- 危险品标志F,Xn
- 安全声明16-36/37
- 危险类别码11-20/21/22-36
欧盟法规
C&L通报上下游产品
(6Ar,9R)-7-甲基-4,6,6A,7,8,9-六氢-吲哚并[4,3-Fg]喹啉-9-甲酰肼 (+/-)-Isolysergic Acid Hydrazide 5256-60-0麦角酸 D-Lysergic Acid 82-58-6
合成工艺路线路线简述
📜Alkaline Earth Salt Of/the/ Methylsulfuric Acid置于正己烷,三氧化硫,乙腈体系中,化学反应生成(8Alpha)-9,10-二去氢-N,N-二乙基-6-甲基麦角灵-8-甲酰胺,麦角乙二胺
参考文献:Us2774763
标题:Us2774763
海关参考信息
- 2901210000-乙烯
2901220000-丙烯
2902500000-苯乙烯
2902600000-乙苯 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:US-2023286975-A1
优先权日:2020-07-07
标题:Improved method for the production of lysergic acid diethylamide (lsd) and novel derivatives thereof
发明人：GRILL MATTHIAS
权利人:COMPASS PATHFINDER LTD
摘要:The present invention provides an improved method for the production of lysergic acid diethylamide (LSD) for GMP purposes. Furthermore, the present invention provides novel LSD derivatives of formula I as well as their synthesis and purification. Due to the affinity of the presented substances for the 5-HT 2A receptor, the invention may find application in numerous forms of therapy, such as against depression or drug addiction.
